Bank Of New York Mellon Corp Clovis Oncology, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.85 $28,850 - $78,309	27,477 Added 38.96%	97,995 $117,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $189,490 - $890,302	-300,778 Reduced 81.01%	70,518 $127,000
Q1 2022 May 11, 2022	BUY	$1.43 - $3.14 $3,768 - $8,273	2,635 Added 0.71%	371,296 $750,000
Q4 2021 Feb 11, 2022	SELL	$2.7 - $4.76 $23,314 - $41,102	-8,635 Reduced 2.29%	368,661 $999,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $312,713 - $446,733	77,023 Added 25.65%	377,296 $1.68 Million
Q2 2021 Aug 11, 2021	SELL	$5.02 - $7.05 $205,734 - $288,930	-40,983 Reduced 12.01%	300,273 $1.74 Million
Q1 2021 May 13, 2021	SELL	$4.81 - $10.34 $395,771 - $850,785	-82,281 Reduced 19.43%	341,256 $2.4 Million
Q4 2020 Feb 09, 2021	BUY	$4.13 - $6.41 $222,540 - $345,396	53,884 Added 14.58%	423,537 $2.03 Million
Q3 2020 Nov 12, 2020	BUY	$4.82 - $7.72 $136,560 - $218,723	28,332 Added 8.3%	369,653 $2.16 Million
Q2 2020 Aug 12, 2020	BUY	$5.69 - $9.69 $331,038 - $563,754	58,179 Added 20.55%	341,321 $2.3 Million
Q1 2020 May 06, 2020	BUY	$3.77 - $11.0 $320,246 - $934,406	84,946 Added 42.86%	283,142 $1.8 Million
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $2,808 - $15,378	-936 Reduced 0.47%	198,196 $2.07 Million
Q3 2019 Nov 07, 2019	SELL	$3.93 - $15.35 $101,712 - $397,273	-25,881 Reduced 11.5%	199,132 $782,000
Q2 2019 Aug 12, 2019	SELL	$12.81 - $25.67 $374,654 - $750,770	-29,247 Reduced 11.5%	225,013 $3.35 Million
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $204,114 - $349,976	11,558 Added 4.76%	254,260 $6.31 Million
Q4 2018 Feb 11, 2019	BUY	$11.63 - $32.67 $141,944 - $398,737	12,205 Added 5.3%	242,702 $4.36 Million
Q3 2018 Nov 09, 2018	SELL	$29.37 - $49.48 $380,752 - $641,458	-12,964 Reduced 5.32%	230,497 $0
Q2 2018 Aug 06, 2018	SELL	$42.06 - $62.4 $504,635 - $748,675	-11,998 Reduced 4.7%	243,461 $11.1 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $183,288 - $247,652	3,657 Added 1.45%	255,459 $13.5 Million
Q4 2017 Feb 09, 2018	BUY	$57.69 - $84.58 $14.5 Million - $21.3 Million	251,802	251,802 $17.1 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account